Kroger Specialty Pharmacy, Inc.

Complete recall history across all FDA and CPSC categories — 67 total recalls

Kroger Specialty Pharmacy, Inc. appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.

Drug Recalls (67)

FDA drug safety enforcement actions by Kroger Specialty Pharmacy, Inc.. Showing most recent 50.

Date Product Reason Class
Apr 3, 2018 Pediasure Liq. Vanilla G+G (CAN) #24 24 days supply, NDC 70074-0558-98 Lack of Processing Controls. Class II
Apr 3, 2018 Temozolomide 20 mg NDC 43975-0253-05 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Tecfidera 240 mg capsule NDC 64406-0006-02 30 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Xalkori 250 mg cap NDC 00069-8140-20 30 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Letrozole 2.5 mg tab NDC 51991-0759-33 30 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Capecitabine 150 mg Tablet NDC 00378-2511-91 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Revlimid 5 mg oral cap NDC 59572-0405-28 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Praluent 75 mg Pen (2 pens/Pkg) NDC 00024-5901-02 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Enbrel PFS 50 mg/mL Inj #4 NDC 58406-0435-04 28 days supply; Lack of Processing Controls. Class II
Apr 3, 2018 Revlimid 25 mg oral cap NDC 59572-0425-21 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Creon DR 24,000 Units Capsule #250 NDC 00032-1224-07 30 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Dupixent 300 mg/2 mL PFS #2 w/ NS NDC 00024-5914-01 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Albuterol 0.083% Inh Sol. 30 days supply, Rx Only, 39183, NDC 76204-0200-60, 30 Lack of Processing Controls. Class II
Apr 3, 2018 Cosentyx 150 mg/mL PFS 300 mg Dose NDC 00078-0639-98, 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Prolia 60 mg/1 mL PF syringe NDC 55513-0710-01 180 days supply. Lack of Processing Controls. Class II
Apr 3, 2018 Kisqali 600 Dose 63 tablet 200 mg NDC 00078-0874-63 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Avonex 30 mcg/0.5 mL PFS Kit NDC 59627-0222-05 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Polyethylene Glycol 3350, powder, for solution 527g BRE, Rx Only, 28 days sup... Lack of Processing Controls. Class II
Apr 3, 2018 Promacta 50 mg tablet NDC 00078-0686-15 30 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Ondansetron 8 mg tablet NDC 57237-0076-30 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Temozolomide 250 mg NDC 43975-0257-05 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Revlimid 15 mg oral cap NDC 59572-0415-21 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Orkambi 200 mg/125 mg Tablets #112 NDC 51167-0809-01 28 days supply. Lack of Processing Controls. Class II
Apr 3, 2018 Kitabis Pak 300 mg/5 mL Soln PARI #56 NDC 24492-0850-56 56 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Revlimid 10 mg oral cap NDC 59572-0410-28 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Sprycel 100 mg tablet NDC 00003-0852-22 30 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Imatinib Mesylate Tablet 400 mg NDC 60505-2901-03 30 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Ibrance 125 mg cap NDC 00069-0189-21 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Revlimid 20 mg oral cap NDC 59572-0420-21 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Cayston 75 mg Inh. Soln. SDV NDC 61958-0901-01 56 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Lupron Depot 22.5 mg 3 month Kit NDC 00074-3346-03 84 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Cyclophosphamide 50 mg cap NDC 00054-0383-25 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Pomalyst 3 mg capsule NDC 59572-0503-21 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Stelara 90 mg/MI PFS NDC 57894-0061-03 84 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Vosevi 400/100/100 mg Tablets #28 NDC 61958-2401-01 28 days supply. Lack of Processing Controls. Class II
Apr 3, 2018 Sodium Chloride 3% Inh. 4 mL NEP #30 NDC 00487-9003-60 30 days supply. Lack of Processing Controls. Class II
Apr 3, 2018 OPDIVO 40 mg/4 mL SDV NDC 00003-3772-11 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Sutent 37.5 mg capsules x28 NDC 00069-0830-38 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Copaxone 40 mg Injection (12) NDC 68546-0325-12 28 days supply. Lack of Processing Controls. Class II
Apr 3, 2018 Repatha 140 mg/mL Sureclick AI 2-pk NDC 55513-0760-02 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Glatiramer Acetate 40 mg/mL NDC 00378-6961-12 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Botox 100 Units Vial NDC 00023-1145-01 90 days supply. Lack of Processing Controls. Class II
Apr 3, 2018 MVW Complete Softgels NDC 58204-0004-00 30 days supply; MVW Complete Chew Vit... Lack of Processing Controls. Class II
Apr 3, 2018 Pulmozyme 1 mg/mL Inh. Soln. #30 NDC 50242-0100-40 30 days supply. Lack of Processing Controls. Class II
Apr 3, 2018 Pulmicort Respules 0.5 mg/2mL s, 30 days supply, NDC 00186-1989-04 Lack of Processing Controls. Class II
Apr 3, 2018 Sprycel 80 mg tablet NDC 00003-0855-22 30 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Xtandi 40 mg capsule NDC 00469-0125-99 30 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Perjeta 420 mg/14 mL SDV Vials 50242-0145-01 21 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Dexamethasone 4 mg tablet NDC 49884-0087-01 28 days supply Lack of Processing Controls. Class II
Apr 3, 2018 Bethkis 300 mg/4 mL Ampule #56 NDC 10122-0820-56 56 days supply Lack of Processing Controls. Class II

View all 67 drug recalls →

Frequently Asked Questions

A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.

Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.

The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.

Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.

Explore More Recalls

Search recalls by category, state, reason, or firm across all our databases.